Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05839210 · ClinicalTrials.gov registry record · NA

Lifestyle Intervention of Food and Exercise for Lymphoma Survivors

A NA study of Non-Hodgkin Lymphoma and Hodgkin Lymphoma, sponsored by University of Miami.

Recruiting
Registry status
NA
Development phase
140
Enrollment target
1
Study location

NCT05839210 is a NA study of Non-Hodgkin Lymphoma and Hodgkin Lymphoma that is actively recruiting participants, run by University of Miami. The registered enrollment target is 140 participants, roughly in line with the 150-participant average among 104 other Non-Hodgkin Lymphoma trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05839210, a NA study of Non-Hodgkin Lymphoma and Hodgkin Lymphoma, is actively recruiting participants, sponsored by University of Miami.

RECRUITING
Registry status
NA
Development phase
140 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to investigate if a mediterranean diet and exercise program for Lymphoma patients during chemotherapy can improve treatment completion and reduce treatment-related side effects.

Interventions

  • BEHAVIORAL LIFE-L Mediterranean Diet
  • BEHAVIORAL LIFE-L Home-Based Exercise Program
  • BEHAVIORAL Supportive Materials

Study Locations (1)

Florida

  • University of Miami - Miami

Trial Details

FieldValue
Enrollment Target 140 participants
Start Date 2023-04-26
Est. Completion 2026-10-31
Phase NA

Sponsor

University of Miami

721 total trials

What the Registry Record Tells You About NCT05839210

The ClinicalTrials.gov registry entry for NCT05839210 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 150-participant average among 104 other Non-Hodgkin Lymphoma trials with a reported enrollment target. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Non-Hodgkin Lymphoma appearing as the primary indexed condition, and to 3 interventions - of which LIFE-L Mediterranean Diet is the first listed.

NCT05839210 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT05839210 about?

NCT05839210 is a clinical study titled "Lifestyle Intervention of Food and Exercise for Lymphoma Survivors". The purpose of this study is to investigate if a mediterranean diet and exercise program for Lymphoma patients during chemotherapy can improve treatment completion and reduce treatment-related side effects.

What is the current status of trial NCT05839210?

This trial is currently recruiting. It is a NA study. The enrollment target is 140 participants. The study started on 2023-04-26. Estimated completion is 2026-10-31.

What conditions does trial NCT05839210 study?

This clinical trial studies the following conditions: Non-Hodgkin Lymphoma, Hodgkin Lymphoma.

What interventions are being tested in trial NCT05839210?

The interventions under investigation include: LIFE-L Mediterranean Diet (BEHAVIORAL), LIFE-L Home-Based Exercise Program (BEHAVIORAL), Supportive Materials (BEHAVIORAL).

Who is sponsoring clinical trial NCT05839210?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05839210 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Non-Hodgkin Lymphoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.